Last reviewed · How we verify

NCT05478668: PPСPGM-EW

Predictors of Pain Chronicity in Patients With Gunshot and Mine-explosive Wounds

Completed Last updated 2 August 2022
What this trial tests

trial testing visual analog scale in Chronic Pain, Widespread in 2,215 participants. Completed in 24 May 2022.

Timeline
24 February 2022
Primary endpoint
24 May 2022
24 May 2022

Quick facts

Lead sponsorBogomolets National Medical University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment2,215
Start date24 February 2022
Primary completion24 May 2022
Estimated completion24 May 2022
Sites1 location across Ukraine

Drugs / interventions tested

Conditions studied

Sponsor

Bogomolets National Medical University

Who can join

Eligibility, male only, with Chronic Pain, Widespread. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

82.1% of patients with gunshot and mine-explosive wounds during hostilities in Ukraine have negative results of pain treatment, which leads to its chronicity. Identifying predictors of pain chronicity in these patients may improve their treatment outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of visual analog scale

Trials testing the same drug.

Other recruiting trials for Chronic Pain, Widespread

Currently open trials in the same condition.

Other Bogomolets National Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05478668.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing